| Year |
Citation |
Score |
| 2023 |
Dion-Albert L, Dudek KA, Russo SJ, Campbell M, Menard C. Neurovascular adaptations modulating cognition, mood, and stress responses. Trends in Neurosciences. 46: 276-292. PMID 36805768 DOI: 10.1016/j.tins.2023.01.005 |
0.548 |
|
| 2022 |
Dion-Albert L, Cadoret A, Doney E, Kaufmann FN, Dudek KA, Daigle B, Parise LF, Cathomas F, Samba N, Hudson N, Lebel M, Campbell M, Turecki G, Mechawar N, et al. Vascular and blood-brain barrier-related changes underlie stress responses and resilience in female mice and depression in human tissue. Nature Communications. 13: 164. PMID 35013188 DOI: 10.1038/s41467-021-27604-x |
0.572 |
|
| 2020 |
Veksler R, Vazana U, Serlin Y, Prager O, Ofer J, Shemen N, Fisher AM, Minaeva O, Hua N, Saar-Ashkenazy R, Benou I, Riklin-Raviv T, Parker E, Mumby G, Kamintsky L, ... ... Campbell M, et al. Slow blood-to-brain transport underlies enduring barrier dysfunction in American football players. Brain : a Journal of Neurology. PMID 32464655 DOI: 10.1093/Brain/Awaa140 |
0.314 |
|
| 2020 |
Hashimoto Y, Campbell M. Tight junction modulation at the blood-brain barrier: Current and future perspectives. Biochimica Et Biophysica Acta. Biomembranes. 1862: 183298. PMID 32353377 DOI: 10.1016/J.Bbamem.2020.183298 |
0.344 |
|
| 2020 |
Hudson N, Cahill M, Campbell M. Inner blood-retina barrier involvement in dry age-related macular degeneration (AMD) pathology. Neural Regeneration Research. 15: 1656-1657. PMID 32209767 DOI: 10.4103/1673-5374.276332 |
0.317 |
|
| 2020 |
Mulfaul K, Ozaki E, Fernando N, Brennan K, Chirco KR, Connolly E, Greene C, Maminishkis A, Salomon RG, Linetsky M, Natoli R, Mullins RF, Campbell M, Doyle SL. Toll-like Receptor 2 Facilitates Oxidative Damage-Induced Retinal Degeneration. Cell Reports. 30: 2209-2224.e5. PMID 32075760 DOI: 10.1016/J.Celrep.2020.01.064 |
0.316 |
|
| 2019 |
Naylor A, Hopkins A, Hudson N, Campbell M. Tight Junctions of the Outer Blood Retina Barrier. International Journal of Molecular Sciences. 21. PMID 31892251 DOI: 10.3390/Ijms21010211 |
0.331 |
|
| 2019 |
Hudson N, Campbell M. Inner Blood-Retinal Barrier Regulation in Retinopathies. Advances in Experimental Medicine and Biology. 1185: 329-333. PMID 31884633 DOI: 10.1007/978-3-030-27378-1_54 |
0.357 |
|
| 2019 |
Hudson N, Celkova L, Hopkins A, Greene C, Storti F, Ozaki E, Fahey E, Theodoropoulou S, Kenna PF, Humphries MM, Curtis AM, Demmons E, Browne A, Liddie S, Lawrence MS, ... ... Campbell M, et al. Dysregulated claudin-5 cycling in the inner retina causes retinal pigment epithelial cell atrophy. Jci Insight. 4. PMID 31391341 DOI: 10.1172/Jci.Insight.130273 |
0.357 |
|
| 2019 |
Campbell M, Doyle SL. Current perspectives on established and novel therapies for pathological neovascularization in retinal disease. Biochemical Pharmacology. 164: 321-325. PMID 31039332 DOI: 10.1016/J.Bcp.2019.04.029 |
0.316 |
|
| 2019 |
Greene C, Hanley N, Campbell M. Claudin-5: gatekeeper of neurological function. Fluids and Barriers of the Cns. 16: 3. PMID 30691500 DOI: 10.1186/S12987-019-0123-Z |
0.366 |
|
| 2019 |
Menard C, Pfau M, Hodes G, Kana V, Wang V, Bouchard S, Takahashi A, Flanigan M, Aleyasin H, LeClair K, Janssen W, Labonte B, Parise E, Lorsch Z, Golden S, ... ... Campbell M, et al. 201. Stress Resilience vs. Vulnerability in Mood disorders, an Integrative Biological Approach Biological Psychiatry. 85: S83-S84. DOI: 10.1016/J.Biopsych.2019.03.215 |
0.557 |
|
| 2018 |
Doherty CP, O'Keeffe E, Keaney J, Lawlor B, Coen RF, Farrell M, Campbell M. Neuropolypathology as a result of severe traumatic brain injury? Clinical Neuropathology. PMID 30336803 DOI: 10.5414/Np301131 |
0.307 |
|
| 2018 |
Kealy J, Greene C, Campbell M. Blood-brain barrier regulation in psychiatric disorders. Neuroscience Letters. PMID 29966749 DOI: 10.1016/J.Neulet.2018.06.033 |
0.34 |
|
| 2018 |
Russo S, Menard C, Pfau M, Hodes G, Kana V, Wang V, Bouchard S, Takahashi A, Flanigan M, Aleyasin H, LeClair K, Janssen W, Labonte B, Parise E, Lorsch Z, ... ... Campbell M, et al. 87. Social Stress Induces Neurovascular Pathology Promoting Immune Infiltration and Depression Biological Psychiatry. 83: S36. DOI: 10.1016/J.Biopsych.2018.02.104 |
0.565 |
|
| 2017 |
Menard C, Pfau ML, Hodes GE, Kana V, Wang VX, Bouchard S, Takahashi A, Flanigan ME, Aleyasin H, LeClair KB, Janssen WG, Labonté B, Parise EM, Lorsch ZS, Golden SA, ... ... Campbell M, et al. Social stress induces neurovascular pathology promoting depression. Nature Neuroscience. 20: 1752-1760. PMID 29184215 DOI: 10.1038/S41593-017-0010-3 |
0.607 |
|
| 2017 |
Greenwood J, Hammarlund-Udenaes M, Jones HC, Stitt AW, Vandenbrouke RE, Romero IA, Campbell M, Fricker G, Brodin B, Manninga H, Gaillard PJ, Schwaninger M, Webster C, Wicher KB, Khrestchatisky M. Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017. Fluids and Barriers of the Cns. 14: 31. PMID 29110676 DOI: 10.1186/S12987-017-0079-9 |
0.303 |
|
| 2017 |
Greene C, Kealy J, Humphries MM, Gong Y, Hou J, Hudson N, Cassidy LM, Martiniano R, Shashi V, Hooper SR, Grant GA, Kenna PF, Norris K, Callaghan CK, Islam MD, ... ... Campbell M, et al. Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia. Molecular Psychiatry. PMID 28993710 DOI: 10.1038/Mp.2017.156 |
0.311 |
|
| 2017 |
Delaney C, Campbell M. The blood brain barrier: Insights from development and ageing. Tissue Barriers. e1373897. PMID 28956691 DOI: 10.1080/21688370.2017.1373897 |
0.319 |
|
| 2017 |
Campbell M, Cassidy PS, O'Callaghan J, Crosbie DE, Humphries P. Manipulating ocular endothelial tight junctions: Applications in treatment of retinal disease pathology and ocular hypertension. Progress in Retinal and Eye Research. PMID 28951125 DOI: 10.1016/J.Preteyeres.2017.09.003 |
0.349 |
|
| 2016 |
O'Keeffe E, Campbell M. Modulating the paracellular pathway at the blood-brain barrier: current and future approaches for drug delivery to the CNS. Drug Discovery Today. Technologies. 20: 35-39. PMID 27986221 DOI: 10.1016/J.Ddtec.2016.07.008 |
0.334 |
|
| 2016 |
Theodoropoulou S, Copland DA, Liu J, Wu J, Gardner PJ, Ozaki E, Doyle SL, Campbell M, Dick AD. Interleukin-33 regulates tissue remodelling and inhibits angiogenesis in the eye. The Journal of Pathology. PMID 27701734 DOI: 10.1002/Path.4816 |
0.338 |
|
| 2016 |
Doherty CP, O'Keefe E, Wallace E, Loftus T, Keaney J, Kealy J, Humphries MM, Molloy MG, Meaney JF, Farrell M, Campbell M. Blood-Brain Barrier Dysfunction as a Hallmark Pathology in Chronic Traumatic Encephalopathy. Journal of Neuropathology and Experimental Neurology. PMID 27245243 DOI: 10.1093/Jnen/Nlw036 |
0.335 |
|
| 2016 |
Greene C, Campbell M. Tight junction modulation of the blood brain barrier: CNS delivery of small molecules. Tissue Barriers. 4: e1138017. PMID 27141420 DOI: 10.1080/21688370.2015.1138017 |
0.347 |
|
| 2016 |
Theodoropoulou S, Doyle S, Copland D, Liu J, Wu J, Campbell M, Dick AD. Role of interleukin 33 in neovascular age-related macular degeneration The Lancet. 387: S99. DOI: 10.1016/S0140-6736(16)00486-4 |
0.329 |
|
| 2015 |
Keaney J, Walsh DM, O'Malley T, Hudson N, Crosbie DE, Loftus T, Sheehan F, McDaid J, Humphries MM, Callanan JJ, Brett FM, Farrell MA, Humphries P, Campbell M. Autoregulated paracellular clearance of amyloid-β across the blood-brain barrier. Science Advances. 1: e1500472. PMID 26491725 DOI: 10.1126/Sciadv.1500472 |
0.317 |
|
| 2015 |
Doyle SL, López FJ, Celkova L, Brennan K, Mulfaul K, Ozaki E, Kenna PF, Kurali E, Hudson N, Doggett T, Ferguson TA, Humphries P, Adamson P, Campbell M. IL-18 Immunotherapy for Neovascular AMD: Tolerability and Efficacy in Nonhuman Primates. Investigative Ophthalmology & Visual Science. 56: 5424-30. PMID 26284546 DOI: 10.1167/Iovs.15-17264 |
0.312 |
|
| 2015 |
Keaney J, Campbell M. The dynamic blood-brain barrier. The Febs Journal. 282: 4067-79. PMID 26277326 DOI: 10.1111/Febs.13412 |
0.337 |
|
| 2015 |
Celkova L, Doyle SL, Campbell M. NLRP3 Inflammasome and Pathobiology in AMD. Journal of Clinical Medicine. 4: 172-92. PMID 26237026 DOI: 10.3390/Jcm4010172 |
0.337 |
|
| 2014 |
Campbell M, Doyle S, Humphries P. IL-18: a new player in immunotherapy for age-related macular degeneration? Expert Review of Clinical Immunology. 10: 1273-5. PMID 25142147 DOI: 10.1586/1744666X.2014.950231 |
0.305 |
|
| 2014 |
Doyle SL, Ozaki E, Brennan K, Humphries MM, Mulfaul K, Keaney J, Kenna PF, Maminishkis A, Kiang AS, Saunders SP, Hams E, Lavelle EC, Gardiner C, Fallon PG, Adamson P, ... ... Campbell M, et al. IL-18 attenuates experimental choroidal neovascularization as a potential therapy for wet age-related macular degeneration. Science Translational Medicine. 6: 230ra44. PMID 24695684 DOI: 10.1126/Scitranslmed.3007616 |
0.345 |
|
| 2014 |
Kiang AS, Humphries MM, Campbell M, Humphries P. Antioxidant therapy for retinal disease. Advances in Experimental Medicine and Biology. 801: 783-9. PMID 24664771 DOI: 10.1007/978-1-4614-3209-8_98 |
0.337 |
|
| 2014 |
Campbell M, Doyle SL, Ozaki E, Kenna PF, Kiang AS, Humphries MM, Humphries P. An overview of the involvement of interleukin-18 in degenerative retinopathies. Advances in Experimental Medicine and Biology. 801: 409-15. PMID 24664725 DOI: 10.1007/978-1-4614-3209-8_52 |
0.347 |
|
| 2014 |
Ozaki E, Campbell M, Kiang AS, Humphries M, Doyle SL, Humphries P. Inflammation in age-related macular degeneration. Advances in Experimental Medicine and Biology. 801: 229-35. PMID 24664703 DOI: 10.1007/978-1-4614-3209-8_30 |
0.336 |
|
| 2013 |
Campbell M, Doyle SL. An eye on the future of inflammasomes and drug development in AMD Journal of Molecular Medicine. 91: 1059-1070. PMID 23661041 DOI: 10.1007/S00109-013-1050-0 |
0.328 |
|
| 2013 |
Campbell M, Humphries MM, Humphries P. Barrier modulation in drug delivery to the retina. Methods in Molecular Biology (Clifton, N.J.). 935: 371-80. PMID 23150382 DOI: 10.1007/978-1-62703-080-9_26 |
0.349 |
|
| 2013 |
Campbell M, Humphries P. The Blood-Retina Barrier Advances in Experimental Medicine and Biology. 763: 70-84. DOI: 10.1007/978-1-4614-4711-5_3 |
0.357 |
|
| 2012 |
Campbell M, Hanrahan F, Gobbo OL, Kelly ME, Kiang AS, Humphries MM, Nguyen AT, Ozaki E, Keaney J, Blau CW, Kerskens CM, Cahalan SD, Callanan JJ, Wallace E, Grant GA, et al. Targeted suppression of claudin-5 decreases cerebral oedema and improves cognitive outcome following traumatic brain injury. Nature Communications. 3: 849. PMID 22617289 DOI: 10.1038/Ncomms1852 |
0.304 |
|
| 2012 |
Doyle SL, Campbell M, Ozaki E, Salomon RG, Mori A, Kenna PF, Farrar GJ, Kiang AS, Humphries MM, Lavelle EC, O'Neill LA, Hollyfield JG, Humphries P. NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nature Medicine. 18: 791-8. PMID 22484808 DOI: 10.1038/Nm.2717 |
0.331 |
|
| 2012 |
Tam LC, Kiang AS, Campbell M, Keaney J, Farrar GJ, Humphries MM, Kenna PF, Humphries P. Protein misfolding and potential therapeutic treatments in inherited retinopathies. Advances in Experimental Medicine and Biology. 723: 567-72. PMID 22183379 DOI: 10.1007/978-1-4614-0631-0_72 |
0.323 |
|
| 2012 |
Hanrahan F, Campbell M, Nguyen AT, Suzuki M, Kiang AS, Tam LC, Gobbo OL, Dhubhghaill SN, Humphries MM, Kenna PF, Humphries P. On further development of barrier modulation as a technique for systemic ocular drug delivery. Advances in Experimental Medicine and Biology. 723: 155-9. PMID 22183328 DOI: 10.1007/978-1-4614-0631-0_21 |
0.349 |
|
| 2012 |
Humphries MM, Kenna PF, Campbell M, Tam LC, Nguyen AT, Farrar GJ, Botto M, Kiang AS, Humphries P. C1q enhances cone photoreceptor survival in a mouse model of autosomal recessive retinitis pigmentosa. European Journal of Human Genetics : Ejhg. 20: 64-8. PMID 21863053 DOI: 10.1038/Ejhg.2011.151 |
0.312 |
|
| 2011 |
Chen J, Stahl A, Krah NM, Seaward MR, Dennison RJ, Sapieha P, Hua J, Hatton CJ, Juan AM, Aderman CM, Willett KL, Guerin KI, Mammoto A, Campbell M, Smith LE. Wnt signaling mediates pathological vascular growth in proliferative retinopathy. Circulation. 124: 1871-81. PMID 21969016 DOI: 10.1161/Circulationaha.111.040337 |
0.319 |
|
| 2011 |
Campbell M, Humphries P. Size-selective and in vitro assessment of inner blood retina barrier permeability. Methods of Molecular Biology. 763: 355-367. PMID 21874464 DOI: 10.1007/978-1-61779-191-8_24 |
0.326 |
|
| 2011 |
Campbell M, Humphries MM, Kiang AS, Nguyen AT, Gobbo OL, Tam LC, Suzuki M, Hanrahan F, Ozaki E, Farrar GJ, Kenna PF, Humphries P. Systemic low-molecular weight drug delivery to pre-selected neuronal regions. Embo Molecular Medicine. 3: 235-45. PMID 21374818 DOI: 10.1002/Emmm.201100126 |
0.345 |
|
| 2010 |
Hanrahan F, Humphries P, Campbell M. RNAi-mediated barrier modulation: synergies of the brain and eye Therapeutic Delivery. 1: 587-594. PMID 22833969 DOI: 10.4155/Tde.10.49 |
0.356 |
|
| 2010 |
Tam LC, Kiang AS, Campbell M, Keaney J, Farrar GJ, Humphries MM, Kenna PF, Humphries P. Prevention of autosomal dominant retinitis pigmentosa by systemic drug therapy targeting heat shock protein 90 (Hsp90). Human Molecular Genetics. 19: 4421-36. PMID 20817636 DOI: 10.1093/Hmg/Ddq369 |
0.314 |
|
| 2010 |
Tam LC, Kiang AS, Chadderton N, Kenna PF, Campbell M, Humphries MM, Farrar GJ, Humphries P. Protection of photoreceptors in a mouse model of RP10. Advances in Experimental Medicine and Biology. 664: 559-65. PMID 20238059 DOI: 10.1007/978-1-4419-1399-9_64 |
0.324 |
|
| 2010 |
Campbell M, Nguyen AT, Kiang AS, Tam L, Kenna PF, Dhubhghaill SN, Humphries M, Farrar GJ, Humphries P. Reversible and size-selective opening of the inner Blood-Retina barrier: a novel therapeutic strategy. Advances in Experimental Medicine and Biology. 664: 301-8. PMID 20238029 DOI: 10.1007/978-1-4419-1399-9_34 |
0.36 |
|
| 2009 |
Campbell M, Nguyen AT, Kiang AS, Tam LC, Gobbo OL, Kerskens C, Ni Dhubhghaill S, Humphries MM, Farrar GJ, Kenna PF, Humphries P. An experimental platform for systemic drug delivery to the retina. Proceedings of the National Academy of Sciences of the United States of America. 106: 17817-22. PMID 19822744 DOI: 10.1073/Pnas.0908561106 |
0.355 |
|
| 2008 |
Campbell M, Kiang A, Kenna PF, Kerskens C, Blau C, O'Dwyer L, Tivnan A, Kelly JA, Brankin B, Farrar G, Humphries P. RNAi-mediated reversible opening of the blood-brain barrier. Journal of Gene Medicine. 10: 930-947. PMID 18509865 DOI: 10.1002/Jgm.1211 |
0.346 |
|
| 2008 |
Tam LC, Kiang AS, Kennan A, Kenna PF, Chadderton N, Ader M, Palfi A, Aherne A, Ayuso C, Campbell M, Reynolds A, McKee A, Humphries MM, Farrar GJ, Humphries P. Therapeutic benefit derived from RNAi-mediated ablation of IMPDH1 transcripts in a murine model of autosomal dominant retinitis pigmentosa (RP10). Human Molecular Genetics. 17: 2084-100. PMID 18385099 DOI: 10.1093/Hmg/Ddn107 |
0.33 |
|
| 2006 |
Campbell M, Humphries M, Kennan A, Kenna P, Humphries P, Brankin B. Aberrant retinal tight junction and adherens junction protein expression in an animal model of autosomal dominant Retinitis pigmentosa: the Rho(-/-) mouse. Experimental Eye Research. 83: 484-92. PMID 16643895 DOI: 10.1016/J.Exer.2006.01.032 |
0.323 |
|
| Show low-probability matches. |